Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Vose

Showing results (51-60 of 299) with videos related to

Pageof 30
Sort By:
Clinical Advances in Hematology & Oncology : H&O|June 17, 2006
Advances in the treatment of hematologic malignancies. Part 1 of a 3-part series: Aggressive lymphomasRichard I Fisher, Bertrand Coiffier, Julie M Vose
Hematology (Amsterdam, Netherlands)|September 29, 2005
Update on lymphoma management: diffuse large B-cell NHLJulie M Vose, M Neumann, Mildred E Harris
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2015
Management of extranodal natural killer/t-cell lymphoma, nasal typeRanjit Kumar Chaudhary, Vijaya Raj Bhatt, Julie M Vose
International Journal of Oncology|May 11, 2006
Dendritic cell-based therapy for mantle cell lymphomaCorey M Munger, Julie M Vose, Shantaram S Joshi
Journal of Thrombosis and Thrombolysis|November 30, 2006
Hematopoietic stem cell transplantation for Hodgkin's disease in a patient with dysfibrinogenemia and thrombosisApar Kishor Ganti, Julie M Vose, William D Haire
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Genetic Cancer Susceptibility Testing: Increased Technology, Increased ComplexityPeter Paul Yu, Julie M Vose, Daniel F Hayes
Seminars in Oncology|May 3, 2003
Establishing an institutional model for the administration of tositumomab and iodine I 131 tositumomabMaribeth A Hohenstein, Samuel C Augustine, Frank Rutar, et al.
Blood Advances|February 26, 2026
Persistence of PET Scan Positivity After Chemoimmunotherapy For DLBCLJames O Armitage, Matthew A Lunning, Julie M Vose, et al.
Oncology (Williston Park, N.Y.)|April 25, 2006
Lymphoma 2006: classification and treatmentJames O Armitage, Philip J Bierman, R Gregory Bociek, et al.
Hematology. American Society of Hematology. Education Program|November 26, 2002
Update on epidemiology and therapeutics for non-Hodgkin's lymphomaJulie M Vose, Brian C-H Chiu, Bruce D Cheson, et al.
Pageof 30

Showing results (51-60 of 299) with videos related to

Sort By:
Pageof 30
Clinical Advances in Hematology & Oncology : H&O|June 17, 2006
Advances in the treatment of hematologic malignancies. Part 1 of a 3-part series: Aggressive lymphomasRichard I Fisher, Bertrand Coiffier, Julie M Vose
Hematology (Amsterdam, Netherlands)|September 29, 2005
Update on lymphoma management: diffuse large B-cell NHLJulie M Vose, M Neumann, Mildred E Harris
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2015
Management of extranodal natural killer/t-cell lymphoma, nasal typeRanjit Kumar Chaudhary, Vijaya Raj Bhatt, Julie M Vose
International Journal of Oncology|May 11, 2006
Dendritic cell-based therapy for mantle cell lymphomaCorey M Munger, Julie M Vose, Shantaram S Joshi
Journal of Thrombosis and Thrombolysis|November 30, 2006
Hematopoietic stem cell transplantation for Hodgkin's disease in a patient with dysfibrinogenemia and thrombosisApar Kishor Ganti, Julie M Vose, William D Haire
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Genetic Cancer Susceptibility Testing: Increased Technology, Increased ComplexityPeter Paul Yu, Julie M Vose, Daniel F Hayes
Seminars in Oncology|May 3, 2003
Establishing an institutional model for the administration of tositumomab and iodine I 131 tositumomabMaribeth A Hohenstein, Samuel C Augustine, Frank Rutar, et al.
Blood Advances|February 26, 2026
Persistence of PET Scan Positivity After Chemoimmunotherapy For DLBCLJames O Armitage, Matthew A Lunning, Julie M Vose, et al.
Oncology (Williston Park, N.Y.)|April 25, 2006
Lymphoma 2006: classification and treatmentJames O Armitage, Philip J Bierman, R Gregory Bociek, et al.
Hematology. American Society of Hematology. Education Program|November 26, 2002
Update on epidemiology and therapeutics for non-Hodgkin's lymphomaJulie M Vose, Brian C-H Chiu, Bruce D Cheson, et al.
Pageof 30